Global

Pharmaceutical Sciences Experts

Gene Cefali


Pharmaceutical Sciences
Solvotrin Therapeutics
Ireland

Biography

Dr. Gene Cefali, Pharm.D., Ph.D. is a drug development consultant assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and the pharmaceutical industry since 2007. Prior to this, Dr. Cefali held positions of increasing responsibility at Kos Pharmaceuticals (acquired by Abbott Laboratories), culminating with the position of Vice President of Lead Optimization. Dr. Cefali is a co-inventor on seven patents as well as an author of many pharmacokinetics manuscripts. Dr. Cefali specialises in assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and pharmaceuticals industry since 2007. He has a proven track record of using his biopharmaceutics and drug development knowledge to significantly add value to a drug venture’s potential success. Dr. Gene Cefali, Pharm.D., Ph.D. is a drug development consultant assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and the pharmaceutical industry since 2007. Prior to this, Dr. Cefali held positions of increasing responsibility at Kos Pharmaceuticals (acquired by Abbott Laboratories), culminating with the position of Vice President of Lead Optimization. Dr. Cefali is a co-inventor on seven patents as well as an author of many pharmacokinetics manuscripts. Dr. Cefali specialises in assisting early-stage pharmaceutical companies with drug development strategy and execution as well as providing pharmaceutical due-diligence expertise to investment companies and pharmaceuticals industry since 2007. He has a proven track record of using his biopharmaceutics and drug development knowledge to significantly add value to a drug venture’s potential success.

Research Interest

biopharmaceutics and drug development

Global Experts from Ireland

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America